Cooper, Dan, Jocelyne Moisan, Belkacem Abdous, and Jean-Pierre Grégoire. 2018. “A POPULATION-BASED COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE AND RISPERIDONE AMONG AMBULATORY PATIENTS WITH SCHIZOPHRENIA”. Journal of Population Therapeutics and Clinical Pharmacology 15 (3). https://jptcp.com/index.php/jptcp/article/view/229.